She says that, regardless of what the drug does medically or physically, its the benefits to her mental health and control over her life that have been the biggest gamechanger
If semaglutide or tirzepatide alone does not produce desired results after 1216 weeks, dose escalation or switching compounds is appropriatenot adding experimental stacks
If a patch product does not clearly state that it contains an approved active drug and provide evidence of transdermal delivery, there is little reason to assume it will reproduce the effects seen with prescription treatment

Risk Factors: Female gender Increasing age Family history (e.g., mother/sister) Genetic mutations (e.g., BRCA1, BRCA2) Early menarche / late menopause Nulliparity or late first pregnancy Use of hormonal therapy Obesity, alcohol consumption Signs and Symptoms: Painless breast lump (most common) Change in breast size or shape Nipple discharge (may be bloody) Skin changes (dimpling, peau dorange) Nipple retraction Swelling or lump in the armpit Diagnosis: Breast self-examination (BSE) Clinical breast examination (CBE) Mammography Ultrasound scan Biopsy (confirmatory test) Management: Surgery (lumpectomy or mastectomy) Chemotherapy Radiotherapy Hormonal therapy (e.g., tamoxifen) Targeted therapy Prevention: Regular screening (BSE, mammography) Healthy lifestyle (weight control, exercise) Limiting alcohol intake Early detection and prompt treatment Nursing Role: Health education on BSE and screening Emotional and psychological support Pre- and post-operative care Monitoring for complications Encouraging adherence to treatment To view or add a comment, sign in How do you have the retinopathy conversation with your hydroxychloroquine candidates

Macdonald, P.L